← Back to patent-cliff list
Cannabidiol Gel (Zynerba)
Tier C — Watch / tradeCannabidiol Gel (Zynerba)
Zynerba Pharmaceuticals Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：CB1, CB2, Serotonin 5-HT1 receptors, Transient receptor potential channels
Brand：Zygel
Indications (approved)：脆性X染色体综合征, DiGeorge综合征
Regional status
US
Phase III
2018-06-12
EU
Phase III
2018-11-09
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Cannabidiol Gel (Zynerba)?
Approved indications include: 脆性X染色体综合征, DiGeorge综合征.
When does the Cannabidiol Gel (Zynerba) patent expire?
No public expiry year is available for Cannabidiol Gel (Zynerba) yet; this page updates once verified.
How do I get a quote for Cannabidiol Gel (Zynerba) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-08